Cost-effectiveness of noninvasive hemodynamic monitoring as a screening tool prior to initiation of inotrope infusion.
Littmann
L
L
Dept. of Internal Medicine, Carolinas Medical Center, Charlotte, NC, USA.
Lasater
M
M
D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000191:economics* / Q000379:methods*; D018570:Risk Assessment; D014481:United States
D002316:Cardiotonic Agents